Trials / Unknown
UnknownNCT05287776
E-cadherin and Integrin Alpha v Beta 1 in Vitiligo
The Effect of Narrow Band UVB on E-cadherin and Integrin Alpha v Beta 1 in Non-segmental Vitiligo: A Novel Proposed Mechanism
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- Sponsor
- Kasr El Aini Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this clinical trial is to study the effect of Narrow Band UVB on E-cadherin and integrin alpha v beta 1 as representatives of adhesion molecules in non-segmental vitiligo in a trial to verify a novel proposed mechanism of Narrow Band UVB. Additionally, specific melanocyte marker (Melan A) will be done to settle the localization of adhesion molecules in relation to melanocytes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Narrow band UVB | Narrow band UVB emitting UVB at wavelength 311nm |
Timeline
- Start date
- 2019-06-01
- Primary completion
- 2022-05-01
- Completion
- 2022-12-01
- First posted
- 2022-03-18
- Last updated
- 2022-03-18
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05287776. Inclusion in this directory is not an endorsement.